Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


New Milestones In Diabetes Treatment

New Milestones In Diabetes Treatment And Understanding Announced At Scientific Congress In Christchurch

Christchurch, New Zealand, Wednesday, 29 August 2001 - Two new milestones in the treatment and prevention of diabetes have been announced at the 34th International Congress of Physiological Sciences, New Zealand's largest ever scientific gathering, being held in Christchurch this week. Garth Cooper, Professor of Biochemistry in the School of Biological Sciences at the University of Auckland, said the discoveries would help alleviate the suffering of thousands of New Zealanders and others around the world with Type 1 and Type 2 diabetes.

Professor Cooper yesterday announced to Congress delegates the discovery of a new mechanism by which insulin-producing cells in the pancreas are destroyed - a major cause of Type 2 diabetes. The knowledge is expected to open up new avenues for the prevention and suppression of this type of diabetes.

"This is a major discovery that has given us a new understanding of how Type 2 diabetes develops over time. Our hope is that this knowledge will enable us to pursue new methods and techniques to prevent the destruction of the body's insulin production system," he said. "Progress like this gives us the motivation to continue doing our research, pursuing successful treatments that combat widespread diseases like diabetes."

Professor Cooper also said that a major step forward in another treatment for diabetes had been achieved over the past week, with the successful final clinical trials of the therapeutic version of the hormone Amylin. This has been found to be effective by the Federal Drug Administration in the United States. Professor Cooper said the drug, based on the hormone that he discovered 15 years ago, was expected to be made available for use by insulin requiring diabetics within the next 12 months.

"It has been a long road, but we are delighted that the drug has been proven and is likely to be available for those suffering with diabetes in the very near future," said Professor Cooper.


© Scoop Media

Business Headlines | Sci-Tech Headlines


MBIE: NZ space sector set to star in Moon mission
The New Zealand space sector is set to star in NASA’s CAPSTONE moon mission – with Rocket Lab launching a satellite to the Moon from New Zealand in June, and the lift-off of a separate NASA-NZ lunar research project... More>>

Air New Zealand: Relaunching 14 International Routes In 16 Days

Air New Zealand is gearing up for the busiest July in two years with the relaunch of 14 international routes in 16 days... More>>

Inland Revenue: Update On Hidden Economy Real Estate Campaign

The Inland Revenue campaign focussing on the real estate sector has resulted in a drop in the amount of private expenses claims being made... More>>

Entrust District: Dividend Will Be Welcomed After Another Tough Year
We’ve all heard of the saying; “if it sounds too good to be true, it probably is” but for Aucklanders within the Entrust District, getting their share of Entrust’s 2022 annual dividend payment really is as good as it sounds... More>>

BusinessNZ: NZ Economy - Prevailing Headwinds
The latest BusinessNZ Planning Forecast reveals business and consumer confidence is low, with factors at home and abroad hampering our recovery... More>>

Specialist Cheesemakers Assn: Shared Cheese Heritage Should Be Shared Not Stripped

As the EU-New Zealand FTA advances New Zealand cheesemakers are urging both Governments to recognise and celebrate the shared cheesemaking heritage that exists between European countries and New Zealand... More>>